We are live on ! Find out more
VCA

Verdence Capital Advisors Portfolio holdings

AUM $1.9B
1-Year Est. Return 36.41%
This Fund
S&P 500
This Quarter Est. Return
+11.88%
1 Year Est. Return
+36.41%
3 Year Est. Return
+97.11%
5 Year Est. Return
+121.09%
10 Year Est. Return
AUM
$813M
AUM Growth
+$88.1M
Cap. Flow
+$14.5M
Cap. Flow %
1.78%
Top 10 Hldgs %
24.07%
Holding
563
New
45
Increased
153
Reduced
266
Closed
67

Top Sells

Rank Stock Value
1
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$17.6M
2
TPL icon
Texas Pacific Land
TPL
+$3.64M
3
MU icon
Micron Technology
MU
+$2.96M
4
C icon
Citigroup
C
+$2.36M
5
ICLR icon
Icon
ICLR
+$2.09M

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.45%
2 Technology 14.22%
3 Financials 12.63%
4 Healthcare 10.42%
5 Energy 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPLN
476
Openlane
OPLN
$4.27B
$162K 0.02%
12,377
-5,169
-29% -$69.3K
ET icon
477
Energy Transfer Partners
ET
$74.1B
$161K 0.02%
13,588
-323
-2% -$3.88K
SHO icon
478
Sunstone Hotel Investors
SHO
$2.02B
$153K 0.02%
15,804
-9,401
-37% -$97.2K
DBI icon
479
Designer Brands
DBI
$264M
$133K 0.02%
13,639
-7,351
-35% -$99.1K
MGNI icon
480
Magnite
MGNI
$3.4B
$126K 0.02%
11,940
-6,244
-34% -$57K
INFN
481
DELISTED
Infinera Corporation Common Stock
INFN
$118K 0.01%
17,491
-12,112
-41% -$73.4K
MAC icon
482
Macerich
MAC
$6.69B
$117K 0.01%
10,364
+364
+4% +$4.11K
DB icon
483
Deutsche Bank
DB
$77.2B
$115K 0.01%
+10,000
New +$98.6K
KRO icon
484
KRONOS Worldwide
KRO
$993M
$107K 0.01%
11,334
+220
+2% +$2.08K
SAN icon
485
Banco Santander
SAN
$216B
$100K 0.01%
33,935
-132
-0.4% -$360
WBD icon
486
Warner Bros
WBD
$70.5B
$100K 0.01%
10,556
-1,367
-11% -$15.4K
ESRT icon
487
Empire State Realty Trust
ESRT
$762M
$84K 0.01%
12,463
-20,374
-62% -$144K
PCSA icon
488
Processa Pharmaceuticals
PCSA
$6.03M
$65.9K 0.01%
120
RMTI icon
489
Rockwell Medical
RMTI
$32.5M
$64.6K 0.01%
6,369
ATAI icon
490
AtaiBeckley Inc
ATAI
$2.7B
$50.8K 0.01%
19,109
ADMA icon
491
ADMA Biologics
ADMA
$2.14B
$46.4K 0.01%
+11,948
New +$36.9K
ZIVO
492
DELISTED
Zivo Bioscience, Inc. Common Stock
ZIVO
$25K ﹤0.01%
1,667
SNCR
493
DELISTED
Synchronoss Technologies
SNCR
$12.4K ﹤0.01%
2,222
DMK
494
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$9.88K ﹤0.01%
834
VWEWW
495
DELISTED
Vintage Wine Estates, Inc. Warrants
VWEWW
$4.3K ﹤0.01%
+14,351
New +$4.98K
ZIVOW
496
DELISTED
Zivo Bioscience, Inc. Warrants
ZIVOW
$701 ﹤0.01%
10,000
ADNT icon
497
Adient
ADNT
$1.45B
-7,261
Closed -$201K
ALGN icon
498
Align Technology
ALGN
$10.9B
-2,717
Closed -$563K
ALK icon
499
Alaska Air
ALK
$4.55B
-7,469
Closed -$292K
EFOR
500
Everforth Inc
EFOR
$1.27B
-2,508
Closed -$227K

Similar funds

Verdence Capital Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Verdence Capital Advisors held 563 positions worth $813M, up 12% from $725M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Verdence Capital Advisors's Q4 2022 filing shows 45 new, 153 increased, 266 reduced and 67 closed positions. Its largest new stake was W.P. Carey: 119,539 shares worth $9.15M. The largest sale was iShares Floating Rate Bond ETF, an estimated $17.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Verdence Capital Advisors's largest Q4 2022 buy was W.P. Carey: 119,539 shares worth $9.15M.
  • Verdence Capital Advisors added most to Vanguard Russell 1000 Value ETF in Q4 2022, an estimated $24.4M increase.
  • Verdence Capital Advisors's biggest Q4 2022 reduction was iShares Floating Rate Bond ETF, cutting an estimated $17.6M.
  • Verdence Capital Advisors fully exited Western Alliance Bancorporation in Q4 2022, selling an estimated $1.87M.
  • Verdence Capital Advisors's ten largest holdings make up 24% of its $813M portfolio in Q4 2022.
  • Verdence Capital Advisors opened 45 new positions and closed 67 in Q4 2022.
  • Verdence Capital Advisors's portfolio value rose 12% quarter-over-quarter to $813M.

Based on Verdence Capital Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.